Skip to main content

Main menu

  • Home
  • Articles
    • Current
    • Published Ahead of Print
    • Archive
    • Supplemental Issues
    • Collections - French
    • Collections - English
  • Info for
    • Authors & Reviewers
    • Submit a Manuscript
    • Advertisers
    • Careers & Locums
    • Subscribers
    • Permissions
  • About CFP
    • About CFP
    • About the CFPC
    • Editorial Advisory Board
    • Terms of Use
    • Contact Us
  • Feedback
    • Feedback
    • Rapid Responses
    • Most Read
    • Most Cited
    • Email Alerts
  • Blogs
    • Latest Blogs
    • Blog Guidelines
    • Directives pour les blogues
  • Mainpro+ Credits
    • About Mainpro+
    • Member Login
    • Instructions
  • Other Publications
    • http://www.cfpc.ca/Canadianfamilyphysician/
    • https://www.cfpc.ca/Login/
    • Careers and Locums

User menu

  • My alerts

Search

  • Advanced search
The College of Family Physicians of Canada
  • Other Publications
    • http://www.cfpc.ca/Canadianfamilyphysician/
    • https://www.cfpc.ca/Login/
    • Careers and Locums
  • My alerts
The College of Family Physicians of Canada

Advanced Search

  • Home
  • Articles
    • Current
    • Published Ahead of Print
    • Archive
    • Supplemental Issues
    • Collections - French
    • Collections - English
  • Info for
    • Authors & Reviewers
    • Submit a Manuscript
    • Advertisers
    • Careers & Locums
    • Subscribers
    • Permissions
  • About CFP
    • About CFP
    • About the CFPC
    • Editorial Advisory Board
    • Terms of Use
    • Contact Us
  • Feedback
    • Feedback
    • Rapid Responses
    • Most Read
    • Most Cited
    • Email Alerts
  • Blogs
    • Latest Blogs
    • Blog Guidelines
    • Directives pour les blogues
  • Mainpro+ Credits
    • About Mainpro+
    • Member Login
    • Instructions
  • RSS feeds
  • Follow cfp Template on Twitter
LetterLetters

Medications for obesity

Joel Lexchin, Ken Bassett, Pierre Biron, Peter Mansfield and Barbara Mintzes
Canadian Family Physician June 2008, 54 (6) 848-849;
Joel Lexchin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ken Bassett
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pierre Biron
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Mansfield
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Barbara Mintzes
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • eLetters
  • Info & Metrics
  • PDF
Loading

In his article on the use of medication in the management of obesity, Dr Sharma states that “there is now abundant evidence from pharmacologic trials that drugs such as orlistat, sibutramine, and rimonabant (a newer compound), when added to lifestyle interventions, can help patients maintain clinically meaningful weight loss for more than 2 years.”1 There are no citations given for this conclusion. The unstated implication is that these drugs can help achieve clinically meaningful results in terms of morbidity and mortality.

One of us searched the Cochrane Library for reviews about the effects of medication on weight-loss maintenance. There was 1 general review about the use of medication2 and 1 for each of the 3 drugs that Dr Sharma mentions.3–5 None of these 4 reviews provide any evidence that the use of these medications results in clinically meaningful patient outcomes, including noticeable average weight loss. The general review examined orlistat and sibutramine. In pharmacotherapeutic trials, of all the participants who withdrew from therapy during the weight-loss phase of the study, 33% were taking orlistat and 43% were taking sibutramine. These people were not followed up with and their outcomes were not reported at the end of the trial period, even though it is a common and ethical practice to follow-up with trial participants and obtain information on key outcomes despite early discontinuation of treatment. As a result, their weight gain or loss was not included in the efficacy estimates. This degree of incomplete reporting negates any scientific conclusions drawn from these studies. The authors of the review concluded that longer and more methodologically rigorous trials were required to fully evaluate any potential benefit of these weight-loss drugs.2

In one of the other studies, the rimonabant group had a similar attrition rate of approximately 40% of participants at the end of 1 year.5 The authors cautioned that results regarding weight loss needed to be viewed tentatively owing to the methodologic limitations of the trials. Their conclusion was that “studies with longer follow-ups after the end of treatment and of more rigorous quality should be done before definitive recommendations can be made regarding the role of this new medication in the management of overweight or obese patients.”

Beyond the issue of the role, if any, of these medications in the management of obesity, this also raises questions about the editorial process at Canadian Family Physician. Editors must ensure that strong claims are not published unless there is supporting evidence. In particular, editors should prevent publication of assertions that claims are supported by evidence when they are not.

  • Copyright© the College of Family Physicians of Canada

References

  1. ↵
    SharmaAMA weighty issue. Medication as a cornerstone of medical obesity managementCan Fam Physician2008544989 (Eng)5001 (Fr)
    OpenUrlFREE Full Text
  2. ↵
    PadwalRLiSKLauDCLong-term pharmacotherapy for obesity and overweightCochrane Database Syst Rev20034CD004094
  3. ↵
    O’MearaSRiemsmaRShirranLMatherLter RietGA rapid and systematic review of the clinical effectiveness and cost-effectiveness of orlistat in the management of obesityHealth Technol Assess2001518181
    OpenUrlPubMed
  4. O’MearaSRiemsmaRShirranLMatherLter RietGThe clinical effectiveness and cost-effectiveness of sibutramine in the management of obesity: a technology assessmentHealth Technol Assess200266197
    OpenUrlPubMed
  5. ↵
    CurioniCAndréCRimonabant for overweight or obesityCochrane Database Syst Rev2006184CD006162
    OpenUrl
PreviousNext
Back to top

In this issue

Canadian Family Physician: 54 (6)
Canadian Family Physician
Vol. 54, Issue 6
1 Jun 2008
  • Table of Contents
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on The College of Family Physicians of Canada.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Medications for obesity
(Your Name) has sent you a message from The College of Family Physicians of Canada
(Your Name) thought you would like to see the The College of Family Physicians of Canada web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Medications for obesity
Joel Lexchin, Ken Bassett, Pierre Biron, Peter Mansfield, Barbara Mintzes
Canadian Family Physician Jun 2008, 54 (6) 848-849;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Share
Medications for obesity
Joel Lexchin, Ken Bassett, Pierre Biron, Peter Mansfield, Barbara Mintzes
Canadian Family Physician Jun 2008, 54 (6) 848-849;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • References
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Excellent chronic pain guideline
  • Treating the vaccine hesitant
  • Reflection on the Outcomes of Training project
Show more Letters

Similar Articles

Navigate

  • Home
  • Current Issue
  • Archive
  • Collections - English
  • Collections - Française

For Authors

  • Authors and Reviewers
  • Submit a Manuscript
  • Permissions
  • Terms of Use

General Information

  • About CFP
  • About the CFPC
  • Advertisers
  • Careers & Locums
  • Editorial Advisory Board
  • Subscribers

Journal Services

  • Email Alerts
  • Twitter
  • RSS Feeds

Copyright © 2022 by The College of Family Physicians of Canada

Powered by HighWire